Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

298
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
298
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

222
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
222
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

489
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

357
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

175
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
175
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

154
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colonoscopy findings and polyp pathology in CHEK2 carriers: a single center experience.

Familial cancer·2026
Same author

Lynch syndrome integrative epidemiology and genetics (LINEAGE): rationale for cohort design.

Familial cancer·2026
Same author

Hereditary Cancer Syndromes.

The American journal of gastroenterology·2024
Same author

Intervention to increase colorectal cancer screening among emergency department patients: results from a randomised pilot study.

Emergency medicine journal : EMJ·2024
Same author

P018 How to Improve Transition of Pediatric IBD Patients Through Use of EMR.

The American journal of gastroenterology·2023
Same author

P041 Successful Reduction in Opioid Prescription for IBD Flare in the Emergency Department: A Retrospective Study and Quality Improvement Initiative.

The American journal of gastroenterology·2023

Related Experiment Video

Updated: Jul 23, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.2K

P053 Interstitial Nephritis from IBD: Complicated Conclusions.

Anna Kepley1, Danielle Marino, Arthur DeCross

  • 1University of Rochester Medical Center, Rochester, Minnesota, United States.

The American Journal of Gastroenterology
|July 18, 2023
PubMed
Summary

Determining the cause of tubulointerstitial nephritis (TIN) in inflammatory bowel disease (IBD) patients is complex. Renal biopsies and consultations often fail to distinguish between medication side effects and IBD as the cause of kidney injury.

More Related Videos

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.0K
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.6K

Related Experiment Videos

Last Updated: Jul 23, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.2K
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.0K
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.6K

Area of Science:

  • Nephrology
  • Gastroenterology
  • Immunology

Background:

  • Kidney injury presents a significant challenge in managing patients with inflammatory bowel disease (IBD).
  • Tubulointerstitial nephritis (TIN) is a known complication of aminosalicylates but has also been observed in drug-naïve IBD patients, suggesting a potential direct link to IBD itself.
  • Differentiating the etiology of TIN in IBD patients is clinically challenging due to multiple confounding factors.

Purpose of the Study:

  • To describe three challenging cases of tubulointerstitial nephritis (TIN) in patients with inflammatory bowel disease (IBD).
  • To illustrate the diagnostic difficulties in attributing renal injury to either IBD medications or the underlying disease process.
  • To highlight the limitations of current diagnostic tools, including renal biopsy and nephrology consultation, in determining the cause of TIN in this population.

Main Methods:

  • Presentation of three distinct cases of IBD patients who developed acute kidney injury.
  • Detailed review of patient histories, including IBD type, medications (aminosalicylates, biologics, immunosuppressants), comorbidities, and clinical presentation.
  • Analysis of renal biopsy findings, diagnostic workups, and nephrology consultations for each case.
  • Discussion of the differential diagnoses for TIN, including drug-induced injury, infection, sarcoidosis, and IBD as an extra-intestinal manifestation.

Main Results:

  • In all three cases, the etiology of TIN remained uncertain despite extensive investigation, including renal biopsies.
  • Nephrology consultations and biopsies did not definitively distinguish between medication-induced injury and IBD as the cause of renal damage.
  • Patients presented with varying degrees of acute and chronic TIN, with features suggestive of drug hypersensitivity, infection, or IBD-related processes.
  • Confounding factors such as hypertension and multiple concomitant medications complicated the diagnostic process in all cases.

Conclusions:

  • The diagnosis of tubulointerstitial nephritis (TIN) in inflammatory bowel disease (IBD) patients is often ambiguous, with diagnostic challenges persisting even after renal biopsy.
  • Current diagnostic approaches may not adequately differentiate between medication side effects and IBD as the primary cause of renal injury.
  • Further research is needed to develop more definitive methods for diagnosing the etiology of TIN in IBD patients, especially considering the increasing use of biologic therapies like adalimumab and vedolizumab.